CooperVision's MiSight 1 Day Becomes First Myopia Control Contact Lens Approved in Japan
核心洞察
CooperVision (搜索)'s MiSight 1 day (搜索) contact lens has received approval from Japan's Ministry of Health, Labor and Welfare (搜索), making it the first soft contact lens authorized for pediatric myopia (搜索) correction and control in Japan.
The approval establishes MiSight 1 day (搜索) as the only contact lens approved for myopia (搜索) control across three major global markets: Japan, the United States, and China.
Japan faces a severe myopia (搜索) epidemic with 77% of children aged 6-11 years and 95% of children aged 12-14 years affected by myopia, representing one of the world's highest childhood myopia rates.
CooperVision (搜索) has achieved a significant regulatory milestone with the approval of its MiSight 1 day (搜索) myopia (搜索) control contact lenses by Japan's Ministry of Health, Labor and Welfare (搜索). This approval marks MiSight 1 day as the first soft contact lens in Japan authorized for use by children to correct myopia and potentially control its progression.
The Japanese approval establishes MiSight 1 day (搜索) as the first and only contact lens approved for myopia (搜索) control in three major global markets: Japan, the United States (FDA approval in November 2019), and China (National Medical Products Administration (搜索) approval in August 2021).
Addressing Japan's Myopia Crisis
Japan faces one of the world's most severe childhood myopia (搜索) epidemics, with staggering prevalence rates that underscore the urgent need for effective interventions. According to CooperVision (搜索)'s announcement, 77% of Japanese children aged 6 to 11 years and 95% of children aged 12 to 14 years are myopic. This positions Japan among countries with the highest myopia rates globally.
The global myopia (搜索) crisis continues to escalate, with approximately 5 billion people estimated to develop myopia by 2050. Against this backdrop, the availability of proven myopia control solutions becomes increasingly critical for preventing long-term ocular health consequences.
Global Market Presence and Clinical Impact
MiSight 1 day (搜索) has established itself as a leading myopia (搜索) management solution worldwide. The daily disposable, dual-focus contact lens is currently available in more than 40 countries and holds CE approval for use in several Asia-Pacific and European markets.
"CooperVision (搜索) is extremely pleased that eyecare professionals and families in Japan will have access to MiSight 1 day (搜索), the world's number one most fitted soft contact lens for myopia (搜索) control in age-appropriate children," said Jennifer Lambert, vice president, myopia management and cornea care at CooperVision.
Lambert emphasized the potential population health impact, stating, "Introducing MiSight 1 day (搜索) as an accessible tool to help treat the myopia (搜索) epidemic among Japanese children has the potential to help prevent longer-term ocular health consequences on a significant scale."
Clinical Implementation and Future Plans
The approval enables Japanese children to access a contact lens technology that is currently being used by hundreds of thousands of children worldwide. Lambert expressed optimism about collaborating with Japan's ophthalmology community, noting the opportunity to "partner with Japan's renowned ophthalmology community to fight myopia (搜索) together."
CooperVision (搜索) plans to announce commercial launch details and initial shipment information in the coming weeks, providing clarity on when Japanese patients and practitioners will have access to this myopia (搜索) control technology.
The regulatory success in Japan represents a strategic expansion for CooperVision (搜索)'s myopia (搜索) management portfolio, particularly given the country's high myopia prevalence and the significant unmet medical need for effective pediatric myopia control solutions.